Black Hawk Acquisition Corp (BKHA): Total Assets
$23.88M
As of 2025-11-30
$26.03M
As of 2026-08-31
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-11-30 | $23.88M | -66.9% | 2026-03-06, Balance as of period end |
| 2024-11-30 | $72.14M | n/m | 2026-03-06, Balance as of period end |
| 2023-11-30 | $263.0K | n/a | 2025-02-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Black Hawk Acquisition Corp (BKHA) | 2025-11-30 | $23.88M | -66.9% |
| Pluri Inc. (PLUR) | 2026-06-30 | $24.88M | -35.7% |
| Champions Oncology, Inc. (CSBR) | 2026-04-30 | $26.99M | -16.6% |
| CEL SCI Corp (CVM) | 2025-09-30 | $28.16M | +4.3% |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $20.23M | -81.5% |
| Curis Inc (CRIS) | 2025-12-31 | $19.97M | -51.6% |
| Outlook Therapeutics, Inc. (OTLK) | 2025-09-30 | $18.58M | -35.5% |
| IN8BIO, Inc. (INAB) | 2025-12-31 | $32.28M | +54.1% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $32.35M | -18.2% |
Compare BKHA, PLUR, CSBR, CVM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗